CA2088679A1 - Method for treating immune system dysfunctions - Google Patents

Method for treating immune system dysfunctions

Info

Publication number
CA2088679A1
CA2088679A1 CA002088679A CA2088679A CA2088679A1 CA 2088679 A1 CA2088679 A1 CA 2088679A1 CA 002088679 A CA002088679 A CA 002088679A CA 2088679 A CA2088679 A CA 2088679A CA 2088679 A1 CA2088679 A1 CA 2088679A1
Authority
CA
Canada
Prior art keywords
immune system
lys
dynorphin
patient
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002088679A
Other languages
English (en)
French (fr)
Inventor
Nancy M. Lee
Sabita Roy
S. Ramakrishnan
Horace H. Loh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2088679A1 publication Critical patent/CA2088679A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
CA002088679A 1990-08-03 1991-08-02 Method for treating immune system dysfunctions Abandoned CA2088679A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56239390A 1990-08-03 1990-08-03
US562,393 1990-08-03

Publications (1)

Publication Number Publication Date
CA2088679A1 true CA2088679A1 (en) 1992-02-04

Family

ID=24246112

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002088679A Abandoned CA2088679A1 (en) 1990-08-03 1991-08-02 Method for treating immune system dysfunctions

Country Status (5)

Country Link
EP (1) EP0541694A1 (ja)
JP (1) JPH06501930A (ja)
AU (1) AU660420B2 (ja)
CA (1) CA2088679A1 (ja)
WO (1) WO1992002547A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817628A (en) * 1992-12-02 1998-10-06 The Rockefeller University Dynorphin a suppression of natural killer cell activity
US20190241660A1 (en) * 2017-12-05 2019-08-08 Intendet Services, Llc Immune-stimulating peptides and checkpoint inhibitors, and uses thereof for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537878A (en) * 1981-10-05 1985-08-27 Tni Pharmaceuticals, Inc. Process for using endogenous enkephalins and endorphins to stimulate the immune system
US4801614A (en) * 1981-10-05 1989-01-31 Tni Pharmaceuticals, Inc. Process for using endogenous enkephalins and endorphins to inhibit growth of tumerous cells
US4757049A (en) * 1981-10-05 1988-07-12 Tni Pharmaceuticals, Inc. Process for using endogenous enkephalins and endorphins to stimulate the immune system of patients with aids

Also Published As

Publication number Publication date
EP0541694A4 (ja) 1994-03-09
JPH06501930A (ja) 1994-03-03
WO1992002547A1 (en) 1992-02-20
AU660420B2 (en) 1995-06-29
EP0541694A1 (en) 1993-05-19
AU8433391A (en) 1992-03-02

Similar Documents

Publication Publication Date Title
Shavit et al. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity
EP0898967B1 (en) Use of transduced myogenic cells for relieving pain and for treating behavioral and perceptive abnormalities
CA2137916A1 (en) Des-tyr dynorphin analogues
US5605885A (en) Method for stimulating the immune system
Dafny et al. Immune response products alter CNS acitivity: Interferon modulates central opioid function
Mastino et al. Combination therapy with thymosin α1 potentiates the anti‐tumor activity of interleukin‐2 with cyclophosphamide in the treatment of the lewis lung carcinoma in mice
CN106668022B (zh) 氨基噻唑类MyD88特异性抑制剂TJM2010-5的应用
Saphier et al. α-Interferon inhibits adrenocortical secretion via μ1-opioid receptors in the rat
Plotnikoff et al. Neuroimmunomodulation with enkephalins: effects on thymus and spleen weights in mice
AU2008282937A1 (en) Methods of treating blood cell depletion
AU660420B2 (en) Method for treating immune system dysfunctions
Tuo et al. The paradoxical role of methionine enkephalin in tumor responses
US5534495A (en) Treatment of non-HIV neuropathic pain syndromes
WO2023024759A1 (zh) 白细胞介素2的融合蛋白及其在als中的应用
AU712606B2 (en) Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
Greenberg et al. Neurohormonal modulation of natural resistance to a murine lymphoma
Yatsugi et al. Anticonvulsive properties of YM-14673, a new TRH analogue, in amygdaloid-kindled rats
US6022536A (en) Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
Roy et al. Dynorphin blocks opioid inhibition of macrophage-colony stimulating factor-induced proliferation of bone marrow cells
Nicoletti et al. Prevention of cyclophosphamide‐induced diabetes in the NOD/WEHI mouse with deoxyspergualin
WO1993002692A1 (en) Method of combatting hiv infections
Deeg et al. In vivo radioprotective effect of AcSDKP on canine myelopoiesis
Arora Neuromodulation of natural killer cell activity
CN110573168A (zh) 治疗与ilc2细胞相关的疾病的方法
Kelley et al. Growth hormone, insulin-like growth factor I, and immune function

Legal Events

Date Code Title Description
FZDE Discontinued